Pfizer, the top pharmaceutical firm, and the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM ...

With its lawsuit filed against Pfizer and BioNTech, the British multinational biopharma has joined the high-profile patent ...

Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...

Pfizer Inc. will shut down its research and development facility in Boulder in the coming months and lay off workers.

Pfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a ...

Shares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its ...

A three-year collaboration between Pfizer and the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), has resulted in a new AI-driven drug discovery method that could ...

Normally, approval from the Food and Drug Administration (FDA) is good news for a biotech stock, and for Pfizer (NYSE:PFE), ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene ...

Pfizer ( PFE -1.82%) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on ...

Beyond analysts' top -and-bottom-line estimates for Pfizer (PFE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

The Best Places to Work assessment is one of the world’s most widely used model to understand employee perceptions about ...